nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.118	0.222	CbGbCtD
L-Carnitine—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.114	0.216	CbGbCtD
L-Carnitine—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.104	0.195	CbGbCtD
L-Carnitine—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.104	0.195	CbGbCtD
L-Carnitine—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.0916	0.173	CbGbCtD
L-Carnitine—CROT—Peroxisomal lipid metabolism—AGPS—acquired immunodeficiency syndrome	0.0179	0.277	CbGpPWpGaD
L-Carnitine—CRAT—Peroxisomal lipid metabolism—AGPS—acquired immunodeficiency syndrome	0.0152	0.235	CbGpPWpGaD
L-Carnitine—MPO—saliva—acquired immunodeficiency syndrome	0.0049	0.0337	CbGeAlD
L-Carnitine—CPT1A—blood plasma—acquired immunodeficiency syndrome	0.00453	0.0312	CbGeAlD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.00442	0.0684	CbGpPWpGaD
L-Carnitine—SLC22A16—blood—acquired immunodeficiency syndrome	0.00335	0.0231	CbGeAlD
L-Carnitine—SLC22A16—bone marrow—acquired immunodeficiency syndrome	0.00325	0.0224	CbGeAlD
L-Carnitine—CROT—skin of body—acquired immunodeficiency syndrome	0.00318	0.0219	CbGeAlD
L-Carnitine—SLC25A20—skin of body—acquired immunodeficiency syndrome	0.00277	0.0191	CbGeAlD
L-Carnitine—CRAT—skin of body—acquired immunodeficiency syndrome	0.00269	0.0185	CbGeAlD
L-Carnitine—SLC25A29—spinal cord—acquired immunodeficiency syndrome	0.00255	0.0175	CbGeAlD
L-Carnitine—CROT—blood—acquired immunodeficiency syndrome	0.00242	0.0167	CbGeAlD
L-Carnitine—MPO—endothelium—acquired immunodeficiency syndrome	0.0024	0.0165	CbGeAlD
L-Carnitine—CPT2—retina—acquired immunodeficiency syndrome	0.00235	0.0162	CbGeAlD
L-Carnitine—CROT—bone marrow—acquired immunodeficiency syndrome	0.00235	0.0162	CbGeAlD
L-Carnitine—SLC25A29—lung—acquired immunodeficiency syndrome	0.00232	0.016	CbGeAlD
L-Carnitine—CROT—vagina—acquired immunodeficiency syndrome	0.00225	0.0155	CbGeAlD
L-Carnitine—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.00219	0.0151	CbGeAlD
L-Carnitine—SLC25A29—nervous system—acquired immunodeficiency syndrome	0.00215	0.0148	CbGeAlD
L-Carnitine—MPO—blood plasma—acquired immunodeficiency syndrome	0.00213	0.0147	CbGeAlD
L-Carnitine—CROT—lung—acquired immunodeficiency syndrome	0.00213	0.0146	CbGeAlD
L-Carnitine—SLC25A20—blood—acquired immunodeficiency syndrome	0.00211	0.0145	CbGeAlD
L-Carnitine—SLC25A29—central nervous system—acquired immunodeficiency syndrome	0.00207	0.0142	CbGeAlD
L-Carnitine—CPT2—skin of body—acquired immunodeficiency syndrome	0.00207	0.0142	CbGeAlD
L-Carnitine—CRAT—blood—acquired immunodeficiency syndrome	0.00205	0.0141	CbGeAlD
L-Carnitine—SLC25A20—bone marrow—acquired immunodeficiency syndrome	0.00204	0.0141	CbGeAlD
L-Carnitine—SLC25A20—spinal cord—acquired immunodeficiency syndrome	0.00203	0.014	CbGeAlD
L-Carnitine—CRAT—bone marrow—acquired immunodeficiency syndrome	0.00198	0.0136	CbGeAlD
L-Carnitine—CRAT—spinal cord—acquired immunodeficiency syndrome	0.00197	0.0136	CbGeAlD
L-Carnitine—CROT—nervous system—acquired immunodeficiency syndrome	0.00197	0.0136	CbGeAlD
L-Carnitine—SLC25A20—vagina—acquired immunodeficiency syndrome	0.00196	0.0135	CbGeAlD
L-Carnitine—CPT1A—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00194	0.03	CbGpPWpGaD
L-Carnitine—CRAT—vagina—acquired immunodeficiency syndrome	0.0019	0.0131	CbGeAlD
L-Carnitine—CROT—central nervous system—acquired immunodeficiency syndrome	0.0019	0.0131	CbGeAlD
L-Carnitine—SLC25A20—lung—acquired immunodeficiency syndrome	0.00185	0.0127	CbGeAlD
L-Carnitine—CRAT—lung—acquired immunodeficiency syndrome	0.00179	0.0124	CbGeAlD
L-Carnitine—CPT1A—digestive system—acquired immunodeficiency syndrome	0.00174	0.012	CbGeAlD
L-Carnitine—SLC25A20—nervous system—acquired immunodeficiency syndrome	0.00171	0.0118	CbGeAlD
L-Carnitine—CRAT—nervous system—acquired immunodeficiency syndrome	0.00166	0.0114	CbGeAlD
L-Carnitine—CPT1A—blood—acquired immunodeficiency syndrome	0.00166	0.0114	CbGeAlD
L-Carnitine—SLC25A20—central nervous system—acquired immunodeficiency syndrome	0.00165	0.0114	CbGeAlD
L-Carnitine—SLC25A29—brain—acquired immunodeficiency syndrome	0.00164	0.0113	CbGeAlD
L-Carnitine—CRAT—central nervous system—acquired immunodeficiency syndrome	0.0016	0.011	CbGeAlD
L-Carnitine—SLC25A29—lymph node—acquired immunodeficiency syndrome	0.00159	0.0109	CbGeAlD
L-Carnitine—CPT2—blood—acquired immunodeficiency syndrome	0.00157	0.0108	CbGeAlD
L-Carnitine—CPT1A—vagina—acquired immunodeficiency syndrome	0.00154	0.0106	CbGeAlD
L-Carnitine—CPT2—bone marrow—acquired immunodeficiency syndrome	0.00152	0.0105	CbGeAlD
L-Carnitine—CPT2—spinal cord—acquired immunodeficiency syndrome	0.00152	0.0104	CbGeAlD
L-Carnitine—CROT—brain—acquired immunodeficiency syndrome	0.0015	0.0104	CbGeAlD
L-Carnitine—CPT2—vagina—acquired immunodeficiency syndrome	0.00146	0.0101	CbGeAlD
L-Carnitine—CPT1A—lung—acquired immunodeficiency syndrome	0.00145	0.01	CbGeAlD
L-Carnitine—CROT—lymph node—acquired immunodeficiency syndrome	0.00145	0.01	CbGeAlD
L-Carnitine—CPT2—lung—acquired immunodeficiency syndrome	0.00138	0.0095	CbGeAlD
L-Carnitine—SLC25A20—brain—acquired immunodeficiency syndrome	0.00131	0.00901	CbGeAlD
L-Carnitine—XDH—digestive system—acquired immunodeficiency syndrome	0.00129	0.00886	CbGeAlD
L-Carnitine—CPT2—nervous system—acquired immunodeficiency syndrome	0.00128	0.0088	CbGeAlD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00128	0.0198	CbGpPWpGaD
L-Carnitine—CRAT—brain—acquired immunodeficiency syndrome	0.00127	0.00875	CbGeAlD
L-Carnitine—SLC25A20—lymph node—acquired immunodeficiency syndrome	0.00126	0.00871	CbGeAlD
L-Carnitine—CPT2—central nervous system—acquired immunodeficiency syndrome	0.00123	0.00847	CbGeAlD
L-Carnitine—CRAT—lymph node—acquired immunodeficiency syndrome	0.00123	0.00845	CbGeAlD
L-Carnitine—XDH—vagina—acquired immunodeficiency syndrome	0.00114	0.00783	CbGeAlD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00109	0.0168	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00109	0.0168	CbGpPWpGaD
L-Carnitine—CPT1A—brain—acquired immunodeficiency syndrome	0.00103	0.00709	CbGeAlD
L-Carnitine—MPO—skin of body—acquired immunodeficiency syndrome	0.00102	0.00706	CbGeAlD
L-Carnitine—CPT1A—lymph node—acquired immunodeficiency syndrome	0.000995	0.00685	CbGeAlD
L-Carnitine—CES1—lymphoid tissue—acquired immunodeficiency syndrome	0.000994	0.00684	CbGeAlD
L-Carnitine—CES1—digestive system—acquired immunodeficiency syndrome	0.000981	0.00676	CbGeAlD
L-Carnitine—CPT2—brain—acquired immunodeficiency syndrome	0.000977	0.00673	CbGeAlD
L-Carnitine—CPT2—lymph node—acquired immunodeficiency syndrome	0.000944	0.0065	CbGeAlD
L-Carnitine—CES1—blood—acquired immunodeficiency syndrome	0.000935	0.00644	CbGeAlD
L-Carnitine—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000843	0.00581	CbGeAlD
L-Carnitine—MPO—lymphoid tissue—acquired immunodeficiency syndrome	0.00083	0.00571	CbGeAlD
L-Carnitine—CES1—lung—acquired immunodeficiency syndrome	0.00082	0.00564	CbGeAlD
L-Carnitine—MPO—digestive system—acquired immunodeficiency syndrome	0.00082	0.00564	CbGeAlD
L-Carnitine—SLCO1B1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000814	0.0126	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.000808	0.0125	CbGpPWpGaD
L-Carnitine—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000803	0.00553	CbGeAlD
L-Carnitine—MPO—blood—acquired immunodeficiency syndrome	0.000781	0.00538	CbGeAlD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	0.000771	0.0119	CbGpPWpGaD
L-Carnitine—CES1—nervous system—acquired immunodeficiency syndrome	0.000759	0.00523	CbGeAlD
L-Carnitine—MPO—bone marrow—acquired immunodeficiency syndrome	0.000755	0.0052	CbGeAlD
L-Carnitine—MPO—spinal cord—acquired immunodeficiency syndrome	0.000752	0.00518	CbGeAlD
L-Carnitine—SLC22A4—digestive system—acquired immunodeficiency syndrome	0.000748	0.00515	CbGeAlD
L-Carnitine—CES1—central nervous system—acquired immunodeficiency syndrome	0.000731	0.00503	CbGeAlD
L-Carnitine—SLC22A4—blood—acquired immunodeficiency syndrome	0.000713	0.00491	CbGeAlD
L-Carnitine—SLC22A5—retina—acquired immunodeficiency syndrome	0.000705	0.00486	CbGeAlD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000699	0.0108	CbGpPWpGaD
L-Carnitine—SLC22A4—bone marrow—acquired immunodeficiency syndrome	0.00069	0.00475	CbGeAlD
L-Carnitine—SLC22A4—spinal cord—acquired immunodeficiency syndrome	0.000687	0.00473	CbGeAlD
L-Carnitine—MPO—lung—acquired immunodeficiency syndrome	0.000684	0.00471	CbGeAlD
L-Carnitine—CROT—Metabolism—TAT—acquired immunodeficiency syndrome	0.000669	0.0103	CbGpPWpGaD
L-Carnitine—SLC22A4—vagina—acquired immunodeficiency syndrome	0.000661	0.00455	CbGeAlD
L-Carnitine—MPO—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.000637	0.00986	CbGpPWpGaD
L-Carnitine—MPO—nervous system—acquired immunodeficiency syndrome	0.000634	0.00437	CbGeAlD
L-Carnitine—SLC22A4—lung—acquired immunodeficiency syndrome	0.000625	0.0043	CbGeAlD
L-Carnitine—SLC22A8—blood—acquired immunodeficiency syndrome	0.000624	0.0043	CbGeAlD
L-Carnitine—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000619	0.00426	CbGeAlD
L-Carnitine—MPO—IL23-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.000612	0.00947	CbGpPWpGaD
L-Carnitine—MPO—central nervous system—acquired immunodeficiency syndrome	0.00061	0.0042	CbGeAlD
L-Carnitine—SLCO1B1—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000603	0.00934	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000591	0.00915	CbGpPWpGaD
L-Carnitine—CES1—brain—acquired immunodeficiency syndrome	0.00058	0.004	CbGeAlD
L-Carnitine—CRAT—Metabolism—TAT—acquired immunodeficiency syndrome	0.000568	0.0088	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—TAT—acquired immunodeficiency syndrome	0.000568	0.0088	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000568	0.0088	CbGpPWpGaD
L-Carnitine—CES1—lymph node—acquired immunodeficiency syndrome	0.000561	0.00386	CbGeAlD
L-Carnitine—MPO—IL23-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000544	0.00842	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.000519	0.00803	CbGpPWpGaD
L-Carnitine—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000507	0.00349	CbGeAlD
L-Carnitine—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000495	0.00341	CbGeAlD
L-Carnitine—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000488	0.00336	CbGeAlD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000485	0.0075	CbGpPWpGaD
L-Carnitine—MPO—brain—acquired immunodeficiency syndrome	0.000484	0.00334	CbGeAlD
L-Carnitine—CRAT—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000483	0.00748	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000483	0.00748	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000474	0.00733	CbGpPWpGaD
L-Carnitine—SLC22A5—blood—acquired immunodeficiency syndrome	0.000472	0.00325	CbGeAlD
L-Carnitine—MPO—lymph node—acquired immunodeficiency syndrome	0.000468	0.00322	CbGeAlD
L-Carnitine—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000455	0.00313	CbGeAlD
L-Carnitine—SLC22A4—brain—acquired immunodeficiency syndrome	0.000442	0.00305	CbGeAlD
L-Carnitine—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000437	0.00301	CbGeAlD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000434	0.00672	CbGpPWpGaD
L-Carnitine—SLC22A4—lymph node—acquired immunodeficiency syndrome	0.000427	0.00294	CbGeAlD
L-Carnitine—MPO—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.000422	0.00653	CbGpPWpGaD
L-Carnitine—SLC22A5—lung—acquired immunodeficiency syndrome	0.000414	0.00285	CbGeAlD
L-Carnitine—MPO—IL23-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.000396	0.00613	CbGpPWpGaD
L-Carnitine—SLC22A8—brain—acquired immunodeficiency syndrome	0.000387	0.00267	CbGeAlD
L-Carnitine—MPO—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000385	0.00596	CbGpPWpGaD
L-Carnitine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000384	0.00148	CcSEcCtD
L-Carnitine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000381	0.00147	CcSEcCtD
L-Carnitine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000381	0.00147	CcSEcCtD
L-Carnitine—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000381	0.00147	CcSEcCtD
L-Carnitine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00038	0.00147	CcSEcCtD
L-Carnitine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00038	0.00147	CcSEcCtD
L-Carnitine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000378	0.00146	CcSEcCtD
L-Carnitine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000377	0.00146	CcSEcCtD
L-Carnitine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000376	0.00145	CcSEcCtD
L-Carnitine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000376	0.00145	CcSEcCtD
L-Carnitine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000374	0.00144	CcSEcCtD
L-Carnitine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000374	0.00144	CcSEcCtD
L-Carnitine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000374	0.00144	CcSEcCtD
L-Carnitine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000373	0.00144	CcSEcCtD
L-Carnitine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000372	0.00144	CcSEcCtD
L-Carnitine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000372	0.00144	CcSEcCtD
L-Carnitine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000371	0.00143	CcSEcCtD
L-Carnitine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000369	0.00142	CcSEcCtD
L-Carnitine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000366	0.00141	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000366	0.00141	CcSEcCtD
L-Carnitine—CPT2—Metabolism—TAT—acquired immunodeficiency syndrome	0.000366	0.00567	CbGpPWpGaD
L-Carnitine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000364	0.0014	CcSEcCtD
L-Carnitine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000363	0.0014	CcSEcCtD
L-Carnitine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000363	0.0014	CcSEcCtD
L-Carnitine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000363	0.0014	CcSEcCtD
L-Carnitine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000363	0.0014	CcSEcCtD
L-Carnitine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000363	0.0014	CcSEcCtD
L-Carnitine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000361	0.00139	CcSEcCtD
L-Carnitine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00036	0.00139	CcSEcCtD
L-Carnitine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00036	0.00139	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00036	0.00139	CcSEcCtD
L-Carnitine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000359	0.00139	CcSEcCtD
L-Carnitine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000358	0.00138	CcSEcCtD
L-Carnitine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000358	0.00138	CcSEcCtD
L-Carnitine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000357	0.00138	CcSEcCtD
L-Carnitine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000357	0.00138	CcSEcCtD
L-Carnitine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000357	0.00138	CcSEcCtD
L-Carnitine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000355	0.00137	CcSEcCtD
L-Carnitine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000355	0.00137	CcSEcCtD
L-Carnitine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000354	0.00137	CcSEcCtD
L-Carnitine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000354	0.00137	CcSEcCtD
L-Carnitine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000354	0.00137	CcSEcCtD
L-Carnitine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000354	0.00137	CcSEcCtD
L-Carnitine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000353	0.00136	CcSEcCtD
L-Carnitine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000352	0.00136	CcSEcCtD
L-Carnitine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000352	0.00136	CcSEcCtD
L-Carnitine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000351	0.00136	CcSEcCtD
L-Carnitine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00035	0.00135	CcSEcCtD
L-Carnitine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00035	0.00135	CcSEcCtD
L-Carnitine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00035	0.00135	CcSEcCtD
L-Carnitine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000349	0.00135	CcSEcCtD
L-Carnitine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00134	CcSEcCtD
L-Carnitine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000347	0.00134	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000347	0.00134	CcSEcCtD
L-Carnitine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000346	0.00134	CcSEcCtD
L-Carnitine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000346	0.00134	CcSEcCtD
L-Carnitine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000345	0.00133	CcSEcCtD
L-Carnitine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000345	0.00133	CcSEcCtD
L-Carnitine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000344	0.00133	CcSEcCtD
L-Carnitine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000344	0.00133	CcSEcCtD
L-Carnitine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000343	0.00132	CcSEcCtD
L-Carnitine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000343	0.00132	CcSEcCtD
L-Carnitine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000343	0.00132	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000342	0.0053	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000341	0.00131	CcSEcCtD
L-Carnitine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00034	0.00131	CcSEcCtD
L-Carnitine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.00131	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00034	0.00131	CcSEcCtD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.00034	0.00526	CbGpPWpGaD
L-Carnitine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00034	0.00131	CcSEcCtD
L-Carnitine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000337	0.0013	CcSEcCtD
L-Carnitine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000337	0.0013	CcSEcCtD
L-Carnitine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000337	0.0013	CcSEcCtD
L-Carnitine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.0013	CcSEcCtD
L-Carnitine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000336	0.0013	CcSEcCtD
L-Carnitine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000335	0.00129	CcSEcCtD
L-Carnitine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000335	0.00129	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000335	0.00519	CbGpPWpGaD
L-Carnitine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000335	0.00129	CcSEcCtD
L-Carnitine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000335	0.00129	CcSEcCtD
L-Carnitine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000334	0.00129	CcSEcCtD
L-Carnitine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000334	0.00129	CcSEcCtD
L-Carnitine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000333	0.00129	CcSEcCtD
L-Carnitine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000333	0.00129	CcSEcCtD
L-Carnitine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000332	0.00128	CcSEcCtD
L-Carnitine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000331	0.00128	CcSEcCtD
L-Carnitine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000331	0.00128	CcSEcCtD
L-Carnitine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00033	0.00127	CcSEcCtD
L-Carnitine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000329	0.00127	CcSEcCtD
L-Carnitine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000328	0.00127	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000325	0.00125	CcSEcCtD
L-Carnitine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000324	0.00125	CcSEcCtD
L-Carnitine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000324	0.00125	CcSEcCtD
L-Carnitine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000324	0.00125	CcSEcCtD
L-Carnitine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000323	0.00125	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00125	CcSEcCtD
L-Carnitine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000323	0.00125	CcSEcCtD
L-Carnitine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00124	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000322	0.00124	CcSEcCtD
L-Carnitine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.00124	CcSEcCtD
L-Carnitine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000322	0.00124	CcSEcCtD
L-Carnitine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00032	0.00124	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.00032	0.00495	CbGpPWpGaD
L-Carnitine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000319	0.00123	CcSEcCtD
L-Carnitine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000319	0.00123	CcSEcCtD
L-Carnitine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000319	0.00123	CcSEcCtD
L-Carnitine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000319	0.00123	CcSEcCtD
L-Carnitine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000318	0.00123	CcSEcCtD
L-Carnitine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000318	0.00123	CcSEcCtD
L-Carnitine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000317	0.00122	CcSEcCtD
L-Carnitine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000316	0.00122	CcSEcCtD
L-Carnitine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000316	0.00122	CcSEcCtD
L-Carnitine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000315	0.00122	CcSEcCtD
L-Carnitine—SLCO1B1—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000315	0.00488	CbGpPWpGaD
L-Carnitine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000315	0.00122	CcSEcCtD
L-Carnitine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.00121	CcSEcCtD
L-Carnitine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000314	0.00121	CcSEcCtD
L-Carnitine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000312	0.0012	CcSEcCtD
L-Carnitine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000312	0.0012	CcSEcCtD
L-Carnitine—CPT2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000311	0.00482	CbGpPWpGaD
L-Carnitine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000311	0.0012	CcSEcCtD
L-Carnitine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00031	0.0012	CcSEcCtD
L-Carnitine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00031	0.0012	CcSEcCtD
L-Carnitine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000309	0.00119	CcSEcCtD
L-Carnitine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000309	0.00119	CcSEcCtD
L-Carnitine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.00119	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000308	0.00119	CcSEcCtD
L-Carnitine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000308	0.00119	CcSEcCtD
L-Carnitine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000308	0.00119	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.000307	0.00475	CbGpPWpGaD
L-Carnitine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000307	0.00118	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000306	0.00474	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000306	0.00474	CbGpPWpGaD
L-Carnitine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000306	0.00118	CcSEcCtD
L-Carnitine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000306	0.00118	CcSEcCtD
L-Carnitine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000305	0.00118	CcSEcCtD
L-Carnitine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000305	0.00118	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00118	CcSEcCtD
L-Carnitine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000304	0.00118	CcSEcCtD
L-Carnitine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000303	0.00117	CcSEcCtD
L-Carnitine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000303	0.00117	CcSEcCtD
L-Carnitine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.00117	CcSEcCtD
L-Carnitine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000302	0.00468	CbGpPWpGaD
L-Carnitine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000301	0.00116	CcSEcCtD
L-Carnitine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000301	0.00116	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000301	0.00116	CcSEcCtD
L-Carnitine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.0003	0.00116	CcSEcCtD
L-Carnitine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.0003	0.00116	CcSEcCtD
L-Carnitine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000298	0.00115	CcSEcCtD
L-Carnitine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000297	0.00115	CcSEcCtD
L-Carnitine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000296	0.00114	CcSEcCtD
L-Carnitine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000295	0.00114	CcSEcCtD
L-Carnitine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000295	0.00114	CcSEcCtD
L-Carnitine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000294	0.00114	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000293	0.00454	CbGpPWpGaD
L-Carnitine—SLC22A5—brain—acquired immunodeficiency syndrome	0.000293	0.00202	CbGeAlD
L-Carnitine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00113	CcSEcCtD
L-Carnitine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000291	0.00112	CcSEcCtD
L-Carnitine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000291	0.00112	CcSEcCtD
L-Carnitine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.00112	CcSEcCtD
L-Carnitine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00029	0.00112	CcSEcCtD
L-Carnitine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00029	0.00112	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.00112	CcSEcCtD
L-Carnitine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.00111	CcSEcCtD
L-Carnitine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000287	0.00111	CcSEcCtD
L-Carnitine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00111	CcSEcCtD
L-Carnitine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000286	0.0011	CcSEcCtD
L-Carnitine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000285	0.0011	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000285	0.0011	CcSEcCtD
L-Carnitine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000283	0.00109	CcSEcCtD
L-Carnitine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000283	0.00109	CcSEcCtD
L-Carnitine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.00109	CcSEcCtD
L-Carnitine—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.000283	0.00195	CbGeAlD
L-Carnitine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.00109	CcSEcCtD
L-Carnitine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.00109	CcSEcCtD
L-Carnitine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00109	CcSEcCtD
L-Carnitine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00109	CcSEcCtD
L-Carnitine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000281	0.00108	CcSEcCtD
L-Carnitine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.00108	CcSEcCtD
L-Carnitine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000279	0.00108	CcSEcCtD
L-Carnitine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.00107	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000276	0.00107	CcSEcCtD
L-Carnitine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000275	0.00106	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000274	0.00106	CcSEcCtD
L-Carnitine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.00106	CcSEcCtD
L-Carnitine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000272	0.00105	CcSEcCtD
L-Carnitine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.00105	CcSEcCtD
L-Carnitine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.00105	CcSEcCtD
L-Carnitine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.00104	CcSEcCtD
L-Carnitine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00027	0.00104	CcSEcCtD
L-Carnitine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00027	0.00104	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00104	CcSEcCtD
L-Carnitine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000268	0.00103	CcSEcCtD
L-Carnitine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000268	0.00103	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000268	0.00414	CbGpPWpGaD
L-Carnitine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000267	0.00103	CcSEcCtD
L-Carnitine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.00103	CcSEcCtD
L-Carnitine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000266	0.00103	CcSEcCtD
L-Carnitine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.00102	CcSEcCtD
L-Carnitine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.00102	CcSEcCtD
L-Carnitine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00101	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000262	0.00405	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00101	CcSEcCtD
L-Carnitine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000261	0.00101	CcSEcCtD
L-Carnitine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00101	CcSEcCtD
L-Carnitine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00101	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.001	CcSEcCtD
L-Carnitine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.001	CcSEcCtD
L-Carnitine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.001	CcSEcCtD
L-Carnitine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000256	0.000988	CcSEcCtD
L-Carnitine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.000985	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—TAT—acquired immunodeficiency syndrome	0.000254	0.00393	CbGpPWpGaD
L-Carnitine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.000974	CcSEcCtD
L-Carnitine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000252	0.000973	CcSEcCtD
L-Carnitine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.000969	CcSEcCtD
L-Carnitine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.000969	CcSEcCtD
L-Carnitine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000251	0.000968	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000249	0.00386	CbGpPWpGaD
L-Carnitine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000249	0.00096	CcSEcCtD
L-Carnitine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000249	0.000959	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.000956	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000247	0.00383	CbGpPWpGaD
L-Carnitine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000247	0.000954	CcSEcCtD
L-Carnitine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000247	0.000952	CcSEcCtD
L-Carnitine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.000942	CcSEcCtD
L-Carnitine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.000938	CcSEcCtD
L-Carnitine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.000924	CcSEcCtD
L-Carnitine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.000924	CcSEcCtD
L-Carnitine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000237	0.000915	CcSEcCtD
L-Carnitine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000237	0.000914	CcSEcCtD
L-Carnitine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.000911	CcSEcCtD
L-Carnitine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.000907	CcSEcCtD
L-Carnitine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.000907	CcSEcCtD
L-Carnitine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000234	0.000905	CcSEcCtD
L-Carnitine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.000903	CcSEcCtD
L-Carnitine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.000902	CcSEcCtD
L-Carnitine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000901	CcSEcCtD
L-Carnitine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.000879	CcSEcCtD
L-Carnitine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.000875	CcSEcCtD
L-Carnitine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000871	CcSEcCtD
L-Carnitine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000868	CcSEcCtD
L-Carnitine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000867	CcSEcCtD
L-Carnitine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000867	CcSEcCtD
L-Carnitine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.000863	CcSEcCtD
L-Carnitine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.000861	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000223	0.00345	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000223	0.00345	CbGpPWpGaD
L-Carnitine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000221	0.000855	CcSEcCtD
L-Carnitine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000842	CcSEcCtD
L-Carnitine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.000839	CcSEcCtD
L-Carnitine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.000839	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000216	0.00334	CbGpPWpGaD
L-Carnitine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000827	CcSEcCtD
L-Carnitine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.000818	CcSEcCtD
L-Carnitine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.00081	CcSEcCtD
L-Carnitine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.00081	CcSEcCtD
L-Carnitine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000803	CcSEcCtD
L-Carnitine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000802	CcSEcCtD
L-Carnitine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.0008	CcSEcCtD
L-Carnitine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000798	CcSEcCtD
L-Carnitine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000779	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000201	0.00311	CbGpPWpGaD
L-Carnitine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000773	CcSEcCtD
L-Carnitine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000773	CcSEcCtD
L-Carnitine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000772	CcSEcCtD
L-Carnitine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000768	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000198	0.00307	CbGpPWpGaD
L-Carnitine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000756	CcSEcCtD
L-Carnitine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000743	CcSEcCtD
L-Carnitine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000737	CcSEcCtD
L-Carnitine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000736	CcSEcCtD
L-Carnitine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000732	CcSEcCtD
L-Carnitine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000728	CcSEcCtD
L-Carnitine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000694	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000173	0.00268	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000173	0.00267	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000169	0.00262	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TAT—acquired immunodeficiency syndrome	0.000168	0.0026	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000165	0.00256	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.00016	0.00247	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000143	0.00222	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000143	0.00221	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.00014	0.00216	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000133	0.00207	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000126	0.00194	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—ALB—acquired immunodeficiency syndrome	0.000117	0.0018	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000109	0.00169	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.94e-05	0.00154	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ALB—acquired immunodeficiency syndrome	9.91e-05	0.00153	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ALB—acquired immunodeficiency syndrome	9.91e-05	0.00153	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	9.45e-05	0.00146	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TAT—acquired immunodeficiency syndrome	8.85e-05	0.00137	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	8.54e-05	0.00132	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	7.53e-05	0.00116	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	6.49e-05	0.001	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ALB—acquired immunodeficiency syndrome	6.39e-05	0.000989	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.39e-05	0.000988	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.8e-05	0.000743	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALB—acquired immunodeficiency syndrome	4.43e-05	0.000685	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.34e-05	0.000672	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.47e-05	0.000536	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.3e-05	0.00051	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALB—acquired immunodeficiency syndrome	2.93e-05	0.000454	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALB—acquired immunodeficiency syndrome	1.54e-05	0.000239	CbGpPWpGaD
